SGCM
KDNY

Sand Grove Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Sand Grove Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-315,973
Closed -$12.1M – 36
2023
Q2 		$12.1M Buy
+315,973
New +$12.1M 1.42% 17